HIV Clinical Trials
Volume 18, 2017 - Issue 5-6
Open access
2,228
Views
15
CrossRef citations to date
0
Altmetric
Review
HIV prevention trial design in an era of effective pre-exposure prophylaxis
Amy CutrellViiV Healthcare, Research Triangle Park, Durham, NC, USACorrespondence[email protected]
, Deborah DonnellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAhttp://orcid.org/0000-0002-0587-7480
, David T. DunnMRC Clinical Trials Unit at UCL, London, UK
, David V. GliddenUniversity of California San Francisco, Epidemiology & Biostatistics Department, CA, USA
, Anneke GroblerClinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, Melbourne, Australia;Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
, Brett HanscomVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
, Britt S. StancilParexel International, Durham, NC, USA
, R. Daniel MeyerPfizer Global Product Development, Groton, CT, USA
, Ronnie WangPfizer Global Product Development, Groton, CT, USA
& Robert L. CuffeViiV Healthcare, Middlesex, UK
show all
Pages 177-188
|
Published online: 17 Oct 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.